NASDAQ
Fate Therapeutics, Inc. (FATE) has a free cash flow growth of -26.75% as of Friday, May 29, 2026. This represents a 1956.42% decrease compared to its 12-month average of 1.44%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.